Abstract:Oral squamous cell carcinoma (OSCC) is one of the most prevalent malignancies worldwide. MicroRNAs (miRNAs or miRs) serve crucial roles in the development of OSCC. miR-196a is upregulated in various tumors; however, the role of miR-196a in OSCC remains unclear. This present study aimed to determine the role and underlying mechanism of miR-196a in OSCC cells. Reverse transcription-quantitative PCR (RT-qPCR) was used to measure miR-196a levels in OSCC cells. MTT assays were also performed to determine cell proliferation. Cell migration was detected using wound healing assays and transwell assays, and cell apoptosis was analyzed via flow cytometry. The results indicated that the expression of miR-196a was increased in OSCC cells compared with normal oral squamous cells. TargetScan and luciferase reporter assays also confirmed that forkhead box O1 (FOXO1) was a target gene of miR-196a. It was demonstrated that FOXO1 small interfering RNA significantly promoted SCC9 cell proliferation and migration, and inhibited cell apoptosis. Furthermore, inhibition of miR-196a suppressed SCC9 cell proliferation and migration, and induced cell apoptosis. However, all effects of the miR-196a inhibitor were reversed following FOXO1 inhibition. Western blotting and RT-qPCR were subsequently performed to determine the effect of miR-196a on the PI3K/Akt signaling pathway. In the present study, transfection of miR-196a inhibitor suppressed the expression of phosphorylated (p)-PI3K and p-Akt, and enhanced the levels of FOXO1, while inhibition of FOXO1 exerted the opposite effects. Furthermore, it was demonstrated that miR-196a mimic significantly enhanced SCC9 cell proliferation and migration, and inhibited cell apoptosis. In conclusion, the results indicated that miR-196a serve as an oncogene in OSCCs. Downregulation of miR-196a inhibited the malignant biological processes of OSCC cells by targeting FOXO1. The current results may provide a novel therapeutic strategy for the treatment of patients with OSCC.

MTFP1 Overexpression Promotes the Growth of Oral Squamous Cell Carcinoma by Inducing ROS Production

HIF1A-dependent Overexpression of MTFP1 Promotes Lung Squamous Cell Carcinoma Development by Activating the Glycolysis Pathway

Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression

Overexpression of PTPRZ1 Regulates p120/ β -Catenin Phosphorylation to Promote Carcinogenesis of Oral Submucous Fibrosis

MCTS1 Promotes Invasion and Metastasis of Oral Cancer by Modifying the EMT Process

MTA1 Promotes Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma Via Activating the MEK/ERK/p90RSK Signaling Pathway

NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma

FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair

MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma

PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells

Mitochondrial outer membrane protein MTUS1/ATIP1 exerts antitumor effects through ROS-induced mitochondrial pyroptosis in head and neck squamous cell carcinoma.

Carnitine palmitoyltransferase 1A promotes mitochondrial fission and regulates autophagy by enhancing MFF succinylation in ovarian cancer

MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma

MUC1 Promotes Cancer Stemness and Predicts Poor Prognosis in Osteosarcoma.

CLPTM1L is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma

Circular RNA Mitochondrial Translation Optimization 1 Homologue (circmto1) Induced by Zinc Finger Protein 460 (ZNF460) Promotes Oral Squamous Cell Carcinoma Progression Through the Microrna Mir-320A / Alpha Thalassemia/mental Retardation, X-linked (ATRX) Axis

MMP1 Promotes Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma.

Investigating the Role and Mechanism of Microrna-196A in Oral Squamous Cell Carcinoma by Targeting FOXO1

Carnitine Palmitoyltransferase 1A Promotes Mitochondrial Fission by Enhancing MFF Succinylation in Ovarian Cancer

HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma Via Activating MMP1/PI3K/Akt Signaling Pathway.